Drug-induced nephropathies.
D000493:Allopurinol / Q000009:adverse effects; D000617:Aminoglycosides / Q000009:adverse effects; D000700:Analgesics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D002216:Captopril / Q000009:adverse effects; D002511:Cephalosporins / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D005921:Glomerulonephritis / Q000473:pathology; D006046:Gold / Q000009:adverse effects; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000502:physiology; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology; D007683:Kidney Tubular Necrosis, Acute / Q000473:pathology; D008094:Lithium / Q000009:adverse effects; D009395:Nephritis, Interstitial / Q000473:pathology; D010396:Penicillamine / Q000009:adverse effects; D010406:Penicillins / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects; D012673:Semustine / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013752:Tetracycline / Q000009:adverse effects; D014293:Trimethadione / Q000009:adverse effects
D000617:Aminoglycosides; D000700:Analgesics; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D002511:Cephalosporins; D004232:Diuretics; D010406:Penicillins; D013449:Sulfonamides; D012673:Semustine; D000493:Allopurinol; D006046:Gold; D008094:Lithium; D002216:Captopril; D013752:Tetracycline; D010396:Penicillamine; D002945:Cisplatin; D014293:Trimethadione; D012293:Rifampin